biological and immunological evaluation of neisseria meningitidis serogroup a outer membrane vesicle as vaccine candidates

نویسندگان

seyed ali delbaz department of hepatitis and aids, pasteur institute of iran, tehran, ir iran

seyed davar siadat department of microbiology, pasteur institute of iran, tehran, ir iran; department of microbiology, pasteur institute of iran, tehran, ir iran. tel: +98-2166968850

mohammad reza aghasadeghi department of hepatitis and aids, pasteur institute of iran, tehran, ir iran

mohamad piryaie department of genetics, faculty of medical sciences, shahid beheshti university of medical sciences, tehran, ir iran

چکیده

conclusions the results showed that the extracted omvs were conformationally stable, and there were no pyrogenic determinants in omv. also the results showed that the omv elicited high level of specific antibodies against n. meningitidis serogroup a. these results indicate that the omv obtained here, can be used as a meningococcal vaccine after further investigation. materials and methods omvs were extracted with deoxycholate and edta, and purification was performed by sequential ultracentrifugation. physicochemical properties of extracted omvs were analyzed by electron microscopy and sds-page. the toxicity of lps content in its was assayed by lal test. the presence of pora as a major component of omv was confirmed by western blot. to study antibodies synthesis after immunization with omv, elisa method was used. also serum bactericidal assay (sba) was performed to determine the serum bactericidal activity against n. meningitidis serogroup a. results the results revealed that the content of protein extracted was 0.1 mg/ml. the electron microscopy showed that intactness of the vesicle in these preparation ranged more than 70%. the sds-page showed that pora as a major immunological part of outer membrane vesicle was located in 35-40kda. lal test showed that the endotoxin activity was around 126eu/ml which is safe for using. the elisa test revealed that the igg total titer was elevated after the first injection. sba indicates that bactericidal antibodies rise after the second dose of booster. background neisseria meningitidis serogroup a, is a major cause of bacterial meningitidis outbreaks in africa and the middle east. while polysaccharide vaccines have been available for many years, these vaccines have many disadvantages including the induction of t-cell independent responses which do not induce memory responses. objectives thus to overcome this problem, in this research outer membrane vesicle (omv) containing pora was extracted and evaluated by biological and immunological methods.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis

An improved detergent-free process has been developed to produce vaccine based on native outer membrane vesicles (NOMV) against Neisseria meningitidis serogroup B. Performance was evaluated with the NonaMen vaccine concept, which provides broad coverage based on nine distinct PorA antigens. Scalable aseptic equipment was implemented, replacing undesirable steps like ultracentrifugation, inactiv...

متن کامل

In Silico Studies of Outer Membrane of Neisseria Meningitidis PorA: Its Expression and Immunogenic Properties

Neisseria meningitidis is a major causative agent of bacterial septicemia and meningitis in humans. Currently, there are no vaccines to prevent disease caused by strains of N.meningitidis serogroup B. The Class 1 Outer Membrane Protein (OMP) has been named porA which is a cation selective transmembrane protein of 45 KDa that forms trimeric pore in the meningococcal outer membrane. PorA from ser...

متن کامل

Polysaccharide of meningococcal group C conjugated to different quantities of outer membrane vesicle from Neisseria meningitidis serogroup B

The immunogenicity to several meningococcal polysaccharide-protein conjugates was evaluated in mice. The purified polysaccharide from N. meningitidis serogroup C (PsC) was linked to different quantities of outer membrane vesicle from N. meningitidis serogroup B (OMV) (3, 6 and 9 mg) as carrier protein, via carbodiimide-mediated reaction. The conjugates were inoculated in Balb/c mice in three do...

متن کامل

Prediction and characterization of T-cell epitopes for epitope vaccine design from outer membrane protein of Neisseria meningitidis serogroup B

Neisseria meningitidis serogroup B (MC58) is a leading cause of meningitis and septicaemia, principally infects the infants and adolescents. No vaccine is available for the prevention of these infections because the serogroup B capsular polysaccharide is unable to stimulate an immune response, due to its similarity with polysialic acid. To overcome these obstacles, we proposed to develop a pept...

متن کامل

Two distinct outer membrane serotype subcomplexes of Neisseria meningitidis serogroup A.

A 350-kilodalton serotype outer membrane complex containing the class 1, 3, and 4 outer membrane proteins was isolated from serogroup A Neisseria meningitidis. Partial denaturation yielded two serotype subcomplexes containing the class 3 and 1 proteins (85 kilodaltons) and the class 3 and 4 proteins (94 kilodaltons), respectively.

متن کامل

Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection

Introduction: Neisseria meningitidis is a major causative agent of bacterial septicemia and meningitis in human. PorA is a major component of the outer membrane of N. meningitidis and functions as a cationic Porin. This study aimed to clone and determine the expression of PorA as the first step for producing a proper antigen in a vaccine study against N. meningitidis. Methods: An approximately ...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
jundishapur journal of microbiology

جلد ۶، شماره ۴، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023